Recommanded Product: 120-14-9. Authors Malasala, S; Ahmad, MN; Akunuri, R; Shukla, M; Kaul, G; Dasgupta, A; Madhavi, YV; Chopra, S; Nanduri, S in ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER published article about in [Malasala, Satyaveni; Akunuri, Ravikumar; Madhavi, Y., V; Nanduri, Srinivas] Natl Inst Pharmaceut Educ & Res NIPER, Dept Med Chem, Hyderabad 500037, Telangana, India; [Ahmad, Md Naiyaz; Shukla, Manjulika; Kaul, Grace; Dasgupta, Arunava; Chopra, Sidharth] CSIR Cent Drug Res Inst, Div Microbiol, Sitapur Rd,Sect 10, Lucknow 226031, Uttar Pradesh, India; [Ahmad, Md Naiyaz; Kaul, Grace; Dasgupta, Arunava; Chopra, Sidharth] AcSIR, Sect 19, Ghaziabad 201002, Uttar Pradesh, India in 2021.0, Cited 58.0. The Name is 3,4-Dimethoxybenzaldehyde. Through research, I have a further understanding and discovery of 120-14-9
Owing to the rapid rise in antibiotic resistance, infectious diseases have become serious threat to public health. There is an urgent need to develop new antimicrobial agents with diverse chemical structures and novel mechanisms of action to overcome the resistance. In recent years, Quinazoline-benzimidazole hybrids have emerged as a new class of antimicrobial agents active against S. aureus and M. tuberculosis. In the current study, we designed and synthesized fifteen new Quinazoline-benzimidazole hybrids and evaluated them for their antimicrobial activity against S. aureus ATCC 29213 and M. tuberculosis H37Rv. These studies led to the identification of nine potent antibacterial agents 8a, 8b, 8c, 8d, 8f, 8g, 8h, 8i and 10c with MICs in the range of 4-64 mu g/mL. Further, these selected compounds were found to possess potent antibacterial potential against a panel of drug-resistant clinical isolates which include methicillin and vancomycin-resistant S. aureus. The selected compounds were found to be less toxic to Vero cells (CC50 = 40->= 200 mu g/mL) and demonstrated a favourable selectivity index. Based on the encouraging results obtained these new benzimidazol-2-yl quinazoline derivatives have emerged as promising antimicrobial agents for the treatment of MDR-S. aureus and Mycobacterial infections. (C) 2020 Elsevier Masson SAS. All rights reserved.
Recommanded Product: 120-14-9. Welcome to talk about 120-14-9, If you have any questions, you can contact Malasala, S; Ahmad, MN; Akunuri, R; Shukla, M; Kaul, G; Dasgupta, A; Madhavi, YV; Chopra, S; Nanduri, S or send Email.
Reference:
Indole alkaloid derivatives as building blocks of natural products from Bacillus thuringiensis and Bacillus velezensis and their antibacterial and antifungal activity study,
,Preparation of Indole Containing Building Blocks for the Regiospecific Construction of Indole Appended Pyrazoles and Pyrroles